CRYO CELL INTERNATIONAL INC

Cryo-Cell International operates as a cellular processing and cryogenic storage company. It conducts business across three primary segments: cellular processing and cryogenic storage for family use, the manufacture of PrepaCyte CB processing system units, and cellular processing and cryogenic storage of cord blood stem cells for public use. The company collects, processes, and preserves stem cells derived from umbilical cord blood and cord tissue. Its principal clients are expectant parents seeking to preserve cellular materials for potential future medical treatments for their newborns or immediate family members.

The company is headquartered in Oldsmar, Florida, where it maintains an 18,000-square-foot facility handling administrative operations, marketing, client services, processing, and specimen storage. Cryo-Cell also owns a 56,000-square-foot facility located in Durham, North Carolina, which primarily houses its cryogenic storage units for specimen preservation. Together with its global affiliates, the organization stores more than 250,000 cord blood and cord tissue specimens worldwide.

Summary of the business section of Cryo Cell International's latest annual report, written by StockData.

“At November 30, 2025, the Company had 72 full-time employees and 4 part-time employees on the staff of the Company.”